These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31202439)

  • 21. Outcome of full pulpotomy in mature permanent molars using 3 calcium silicate-based materials: A parallel, double blind, randomized controlled trial.
    Taha NA; Al-Rawash MH; Imran ZA
    Int Endod J; 2022 May; 55(5):416-429. PubMed ID: 35152464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the formocresol versus mineral trioxide aggregate primary molar pulpotomy: a meta-analysis.
    Peng L; Ye L; Tan H; Zhou X
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):e40-4. PubMed ID: 17138165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mineral trioxide aggregate versus formocresol pulpotomy: a systematic review and meta-analysis of randomized clinical trials.
    Shirvani A; Asgary S
    Clin Oral Investig; 2014 May; 18(4):1023-1030. PubMed ID: 24452827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MTA and biodentine for primary teeth pulpotomy: a systematic review and meta-analysis of clinical trials.
    Stringhini Junior E; Dos Santos MGC; Oliveira LB; Mercadé M
    Clin Oral Investig; 2019 Apr; 23(4):1967-1976. PubMed ID: 30238414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Success rates of mineral trioxide aggregate, ferric sulfate, and formocresol pulpotomies: a 24-month study.
    Erdem AP; Guven Y; Balli B; Ilhan B; Sepet E; Ulukapi I; Aktoren O
    Pediatr Dent; 2011; 33(2):165-70. PubMed ID: 21703067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and comparison of white mineral trioxide aggregate and formocresol medicaments in primary tooth pulpotomy: clinical and radiographic study.
    Jayam C; Mitra M; Mishra J; Bhattacharya B; Jana B
    J Indian Soc Pedod Prev Dent; 2014; 32(1):13-8. PubMed ID: 24531596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: Clinical and radiographic study.
    Carti O; Oznurhan F
    Niger J Clin Pract; 2017 Dec; 20(12):1604-1609. PubMed ID: 29378994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentine: A Prospective Randomized Clinical Trial.
    Awawdeh L; Al-Qudah A; Hamouri H; Chakra RJ
    J Endod; 2018 Nov; 44(11):1603-1609. PubMed ID: 30292451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineral Trioxide Aggregate and Diluted Formocresol Pulpotomy: Prospective and Retrospective Study Outcomes.
    Ghoniem N; Vaidyanathan V; Zealand CM; Sushynski JM; Mettlach SM; Botero TM; Majewski RF; Boynton JR; Hu JC
    J Mich Dent Assoc; 2018 Apr; 100(4):40-65. PubMed ID: 30636813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Clinical and Radiographic Success Rate of Formocresol-based Pulpotomy versus Collagen-based Pulpotomy: An
    Anandan V; Inbanathan J; Saket P; Krishnamoorthy V; Gandhi S; Chandrababu VK
    J Contemp Dent Pract; 2021 Jun; 22(6):680-685. PubMed ID: 34393127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical observation and histopathological evaluation of pulp after pulpotomy of primary teeth with formocresol and biodentine.
    Guang J; Li J; Hao L
    Cell Mol Biol (Noisy-le-grand); 2022 May; 68(5):83-88. PubMed ID: 36029512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodentine
    El Meligy OAES; Alamoudi NM; Allazzam SM; El-Housseiny AAM
    BMC Oral Health; 2019 Jan; 19(1):3. PubMed ID: 30612569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth.
    Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S
    Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineral trioxide aggregate as a pulpotomy medicament: an evidence-based assessment.
    Ng FK; Messer LB
    Eur Arch Paediatr Dent; 2008 Jun; 9(2):58-73. PubMed ID: 18534173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of pulpotomy in primary teeth comparing MTA, calcium hydroxide, ferric sulphate, and electrosurgery with formocresol.
    Stringhini Junior E; Vitcel ME; Oliveira LB
    Eur Arch Paediatr Dent; 2015 Aug; 16(4):303-12. PubMed ID: 25833280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of pulpal responses to pulpotomy and pulp capping with biodentine and mineral trioxide aggregate in dogs.
    De Rossi A; Silva LA; Gatón-Hernández P; Sousa-Neto MD; Nelson-Filho P; Silva RA; de Queiroz AM
    J Endod; 2014 Sep; 40(9):1362-9. PubMed ID: 25146016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of mineral trioxide aggregate and formocresol as pulp medicaments for pulpotomies in primary molars.
    Noorollahian H
    Br Dent J; 2008 Jun; 204(11):E20. PubMed ID: 18425074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol.
    Holan G; Eidelman E; Fuks AB
    Pediatr Dent; 2005; 27(2):129-36. PubMed ID: 15926290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and radiographic evaluation of white MTA versus formocresol pulpotomy: A 48-month follow-up study.
    Biedma Perea M; Solano Mendoza B; Garcia-Godoy F; Mendoza Mendoza A; Iglesias-Linares A
    Am J Dent; 2017 Jun; 30(3):131-136. PubMed ID: 29178757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and radiographic outcomes of pulpotomized primary molars treated with white or gray mineral trioxide aggregate and ferric sulfate--long-term follow-up.
    Frenkel G; Kaufman A; Ashkenazi M
    J Clin Pediatr Dent; 2012; 37(2):137-41. PubMed ID: 23534318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.